Development of Multiplexed Infectious Disease Lateral Flow Assays: Challenges and Opportunities

Diagnostics - Tập 7 Số 3 - Trang 51
Khayriyyah Mohd Hanafiah1,2, Norsyahida Arifin3, Yazmin Bustami2, Rahmah Noordin3, Mary L. Garcia1, David A. Anderson1
1Life Sciences, Macfarlane Burnet Institute, Melbourne 3004, Australia
2School of Biological Sciences, Universiti Sains Malaysia, Penang 11800, Malaysia
3Institute for Research in Molecular Medicine, Universiti Sains Malaysia, Penang, 11800, Malaysia

Tóm tắt

Lateral flow assays (LFAs) are the mainstay of rapid point-of-care diagnostics, with the potential to enable early case management and transform the epidemiology of infectious disease. However, most LFAs only detect single biomarkers. Recognizing the complex nature of human disease, overlapping symptoms and states of co-infections, there is increasing demand for multiplexed systems that can detect multiple biomarkers simultaneously. Due to innate limitations in the design of traditional membrane-based LFAs, multiplexing is arguably limited to a small number of biomarkers. Here, we summarize the need for multiplexed LFA, key technical and operational challenges for multiplexing, inherent in the design and production of multiplexed LFAs, as well as emerging enabling technologies that may be able to address these challenges. We further identify important areas for research in efforts towards developing multiplexed LFAs for more impactful diagnosis of infectious diseases.

Từ khóa


Tài liệu tham khảo

Garcia, 2013, Point-of-care testing and the control of infectious diseases, Biomark. Med., 7, 333, 10.2217/bmm.13.57

Zhang, 2009, Immunochromatographic lateral flow strip tests, Methods Mol. Biol., 504, 169, 10.1007/978-1-60327-569-9_12

Weidemaier, 2015, Advancing Rapid Point-of-care Viral Diagnostics to a Clinical Setting, Future Virol., 10, 313, 10.2217/fvl.14.117

Marquez, 2012, No more disease silos for sub-Saharan Africa, BMJ, 345, e5812, 10.1136/bmj.e5812

Bottcher, 2015, Disease-induced resource constraints can trigger explosive epidemics, Sci. Rep., 5, 16571, 10.1038/srep16571

Omilabu, 2016, The West African ebola virus disease epidemic 2014–2015: A commissioned review, Niger. Postgrad. Med. J., 23, 49, 10.4103/1117-1936.186299

Rudolf, 2017, Influence of Referral Pathway on Ebola Virus Disease Case-Fatality Rate and Effect of Survival Selection Bias, Emerg. Infect. Dis., 23, 597, 10.3201/eid2304.160485

Baumann, 2014, Serologic diagnosis of tuberculosis by combining Ig classes against selected mycobacterial targets, J. Infect., 69, 581, 10.1016/j.jinf.2014.05.014

Liu, 2017, Serological biomarker screening and host factor analysis elucidating immune response heterogeneity in active pulmonary tuberculosis, Trop. Biomed., 34, 1

Luka, 2015, Microfluidics Integrated Biosensors: A Leading Technology towards Lab-on-a-Chip and Sensing Applications, Sensors, 15, 30011, 10.3390/s151229783

Wang, D.S., and Fan, S.K. (2016). Microfluidic Surface Plasmon Resonance Sensors: From Principles to Point-of-Care Applications. Sensors, 16.

Dincer, 2017, Multiplexed Point-of-Care Testing-xPOCT, Trends Biotechnol., 35, 728, 10.1016/j.tibtech.2017.03.013

Koczula, 2016, Lateral flow assays, Essays Biochem., 60, 111, 10.1042/EBC20150012

Peeling, 2010, Point-of-care tests for diagnosing infections in the developing world, Clin. Microbiol. Infect., 16, 1062, 10.1111/j.1469-0691.2010.03279.x

Price, 2014, Existing and Emerging Technologies for Point-of-Care Testing, Clin. Biochem. Rev., 35, 155

Korf, 2009, Lateral flow (immuno) assay: Its strengths, weaknesses, opportunities and threats. A literature survey, Anal. Bioanal. Chem., 393, 569, 10.1007/s00216-008-2287-2

Haushalter, 2016, Multiplex Flow Assays, ACS Omega, 1, 586, 10.1021/acsomega.6b00188

Ellington, 2010, Antibody-based protein multiplex platforms: Technical and operational challenges, Clin. Chem., 56, 186, 10.1373/clinchem.2009.127514

Dejnirattisai, 2016, Dengue virus sero-cross-reactivity drives antibody-dependent enhancement of infection with zika virus, Nat. Immunol., 17, 1102, 10.1038/ni.3515

Arifin, 2013, Laboratory detection of strongyloidiasis: IgG-, IgG4—And IgE-ELISAs and cross-reactivity with lymphatic filariasis, Parasite Immunol., 35, 174, 10.1111/pim.12029

Zhao, 2016, Rapid multiplex detection of 10 foodborne pathogens with an up-converting phosphor technology-based 10-channel lateral flow assay, Sci Rep., 6, 21342, 10.1038/srep21342

Propper, C.R., Tester, J.T., Vail, T.L., and Venkatraman, N. (2013). Rapid Multiplex Lateral Flow Assay Device. (13/869,913), U.S. Patent.

O’Farrell, B. (2017, September 07). Multiplex Lateral Flow Assays 2015. Available online: http://www.slideshare.net/ofarreb/multiplexing-and-arraying-in-lateral-flow-assays.

Yen, 2015, Multicolored silver nanoparticles for multiplexed disease diagnostics: Distinguishing dengue, yellow fever, and Ebola viruses, Lab. Chip., 15, 1638, 10.1039/C5LC00055F

Corstjens, 2011, Lateral flow assay for simultaneous detection of cellular- and humoral immune responses, Clin. Biochem., 44, 1241, 10.1016/j.clinbiochem.2011.06.983

Lee, 2015, Multiplex diagnosis of viral infectious diseases (AIDS, hepatitis C, and hepatitis A) based on point of care lateral flow assay using engineered proteinticles, Biosens. Bioelectron., 69, 213, 10.1016/j.bios.2015.02.033

Le, 2017, Dual Recognition Element Lateral Flow Assay Toward Multiplex Strain Specific Influenza Virus Detection, Anal. Chem., 89, 6781, 10.1021/acs.analchem.7b01149

Saxena, S.K. (2016). Phage Display-Derived Antibodies: Application of Recombinant Antibodies for Diagnostics. Proof and Concepts in Rapid Diagnostic Tests and Technologies, InTech.

Rey, 2017, Mitigating the Hook Effect in Lateral Flow Sandwich Immunoassays Using Real-Time Reaction Kinetics, Anal. Chem., 89, 5095, 10.1021/acs.analchem.7b00638

Yetisen, 2017, Multiplex Smartphone Diagnostics, Methods Mol. Biol., 1546, 295, 10.1007/978-1-4939-6730-8_26

Guo, 2015, Mobile device for disease diagnosis and data tracking in resource-limited settings, Methods Mol. Biol., 1256, 3, 10.1007/978-1-4939-2172-0_1

Laksanasopin, 2015, A smartphone dongle for diagnosis of infectious diseases at the point of care, Sci. Transl. Med., 7, 273re1, 10.1126/scitranslmed.aaa0056

Bastarache, 2014, Validation of a multiplex electrochemiluminescent immunoassay platform in human and mouse samples, J. Immunol. Methods, 408, 13, 10.1016/j.jim.2014.04.006

Bastarache, 2011, Accuracy and reproducibility of a multiplex immunoassay platform: A validation study, J. Immunol. Methods, 367, 33, 10.1016/j.jim.2011.01.005

Jani, 2016, Recommendations for Use and Fit-for-Purpose Validation of Biomarker Multiplex Ligand Binding Assays in Drug Development, AAPS J., 18, 1, 10.1208/s12248-015-9820-y

Thông tin
Thông tin xuất bản

Diagnostics

Tập 7 Số 3

51

Thông tin tác giả